The NingLab focuses on Artificial Intelligence (AI), particularly generative AI (genAI), for Science (AI4Science), with applications in drug discovery (e.g., drug design via 2D molecular graph generation and 3D molecule shape generation, peptide generation), healthcare and medicine (e.g., drug repurposing and early onset detection for Alzheimer’s diseases, electronic health record retrieval and predictive analysis, cancer drug selection), and Recommender Systems (e.g., sequential recommendation, recommendation based on LLMs).
The research at Ning Lab has been funded by NSF, NLM, NIMH, NIAMS, NIGMS, NIA, NCATS, AIM-AHEAD, AWS, NEC Labs America, Regenstrief Institute, Sanofi, and OSU President’s Research Excellence Program.